OtherClinical Investigations (Human)
11C-choline PET/CT in recurrent prostate cancer: retrospective analysis in a large US patient series
Laure Michaud, Karim Touijer, Audrey Mauguen, Michael Zelefsky, Michael Morris, Serge Lyashschenko, Jeremy Durack, John Humm, Wolfgang Weber and Heiko Schöder
Journal of Nuclear Medicine December 2019, jnumed.119.233098; DOI: https://doi.org/10.2967/jnumed.119.233098
Laure Michaud
Memorial Sloan Kettering Cancer Center, United States
Karim Touijer
Memorial Sloan Kettering Cancer Center, United States
Audrey Mauguen
Memorial Sloan Kettering Cancer Center, United States
Michael Zelefsky
Memorial Sloan Kettering Cancer Center, United States
Michael Morris
Memorial Sloan Kettering Cancer Center, United States
Serge Lyashschenko
Memorial Sloan Kettering Cancer Center, United States
Jeremy Durack
Memorial Sloan Kettering Cancer Center, United States
John Humm
Memorial Sloan Kettering Cancer Center, United States
Wolfgang Weber
Memorial Sloan Kettering Cancer Center, United States
Heiko Schöder
Memorial Sloan Kettering Cancer Center, United States

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 6
June 1, 2025
11C-choline PET/CT in recurrent prostate cancer: retrospective analysis in a large US patient series
Laure Michaud, Karim Touijer, Audrey Mauguen, Michael Zelefsky, Michael Morris, Serge Lyashschenko, Jeremy Durack, John Humm, Wolfgang Weber, Heiko Schöder
Journal of Nuclear Medicine Dec 2019, jnumed.119.233098; DOI: 10.2967/jnumed.119.233098
11C-choline PET/CT in recurrent prostate cancer: retrospective analysis in a large US patient series
Laure Michaud, Karim Touijer, Audrey Mauguen, Michael Zelefsky, Michael Morris, Serge Lyashschenko, Jeremy Durack, John Humm, Wolfgang Weber, Heiko Schöder
Journal of Nuclear Medicine Dec 2019, jnumed.119.233098; DOI: 10.2967/jnumed.119.233098
Jump to section
Related Articles
Cited By...
- No citing articles found.